Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
Cancer Pathogenesis and Therapy is Scopus-indexed (Q1, CiteScore 6.2), WoS ESCI, DOAJ. Published by Chinese Medical Association.
Checked against the index lists dated .
ISSN 2097-2563Verify ISSN ↗2949-7132Verify ISSN ↗
Publisher: Chinese Medical Association
Cost to publish: Checking DOAJ for article charges…
| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Pathology and Forensic Medicine | 35 / 209 | 83rd | Q1 |
| Oncology | 102 / 428 | 76th | Q1 |
| Histology | 16 / 62 | 75th | Q1 |
| Cancer Research | 89 / 233 | 62nd | Q2 |
Not listed in: ABDC, ABS / AJG, FT50, UT Dallas, ONOS (subscription), ONOS (APC covered)
Yes — actively indexed in Scopus, coverage 2023–present, best quartile Q1, CiteScore 6.2.
Cancer Pathogenesis and Therapy is Q1 in Pathology and Forensic Medicine (rank 35 of 209), Q1 in Oncology (rank 102 of 428) and Q1 in Histology (rank 16 of 62), by CiteScore 2025. It is ranked in 4 subject areas in all.
Cancer Pathogenesis and Therapy is indexed in the Emerging Sources Citation Index, so it may have a Journal Impact Factor in Clarivate's Journal Citation Reports. JCR is paid, so check it for the current value. The closest free measure is its Scopus CiteScore 6.2, which places it in quartile Q1 at the 83rd percentile of its subject. Its SCImago Journal Rank (SJR, a free Scopus-based metric) is 0.889, quartile Q1, with an H-index of 13.
The publisher lists an article processing charge of about US$1,100 for open access (source: OpenAlex). Many journals also publish by the subscription route at no cost to the author, so confirm on the journal's own website.
Cancer Pathogenesis and Therapy is published by Chinese Medical Association. Its print ISSN is 2097-2563 and its online ISSN is 2949-7132.
Yes — indexed in the Emerging Sources Citation Index.
Yes — it is an open-access journal, listed in DOAJ.
Cancer Pathogenesis and Therapy has an h-index of 22 and a 2-year mean of 6.06 citations per paper (OpenAlex). Its Scopus CiteScore is 6.2, quartile Q1. On 2-year citations it ranks #5 of 208 Scopus journals in Pathology and Forensic Medicine.
Cancer Pathogenesis and Therapy published 67 papers in 2025. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
In its latest 82 research articles (2024–2026), authors are most often from China (56.1%), India (17.5%) and United States (9.3%). More than half of recent authorship comes from one country.
Countries are counted fractionally, so a paper by authors from two countries counts half to each.
Scopus status: Active. No retracted papers are recorded. The Problematic Paper Screener flags none of its papers. These are indicators to check, not findings against the journal.
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.